Portfolio company
TYRX
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops antibacterial mesh envelopes for implanted medical devices to reduce surgical-site infections for cardiac and neurological patients.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
CVRx
This company develops implantable neuromodulation devices that stimulate the baroreflex to treat heart failure and hypertension for clinical institutions and their patients.
TYBR Health
This company develops a hydrogel system for orthopaedic surgeons to protect tendons and ligaments from internal scarring following surgical procedures.
Nyra Medical
The company develops a transcatheter cardiac implant to treat mitral regurgitation for patients requiring minimally invasive heart valve repair.
Haermonics
This company develops automated pericardial flushing systems to prevent blood clots and drainage complications for patients recovering from open-heart surgery.
Intrinsic Therapeutics
This company manufactures spinal implants for surgeons to reduce the risk of recurring disc herniations in patients undergoing discectomy procedures.
Cardiac Dimensions
This company develops minimally invasive heart implants to treat functional mitral regurgitation in patients with heart failure.
Aortyx
This company develops bioresorbable endovascular patches and catheter delivery systems for surgeons to treat patients with aortic dissection and other vascular diseases.
AMR Bio
This biotechnology company develops topical antimicrobial gels to prevent post-surgical infections for healthcare providers and patients undergoing surgery.
